A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

Authors: Buti M.1; Mas A.; Prieto M.; Casafont F.; Gonzalez A.; Miras M.; Herrero J.-I.; Jardi R.; Cruz de Castro E.; Garcia-Rey C.

Source: Journal of Hepatology, Volume 38, Number 6, June 2003 , pp. 811-817(7)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Hepatitis B immune globulin; Lamivudine; Liver transplantation; Hepatitis B; Recurrence

Language: English

Document Type: Research article

DOI: 10.1016/S0168-8278(03)00087-4

Affiliations: 1: Servicio de Hepatologia, Hospital General Universitario Valle de Hebron, Paseo Valle de Hebron 119, 08035, Barcelona, Spain

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A